secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0000310764-26-000025
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q1 net sales $6.0B up 2.6%; adjusted EPS down 8.5% to $2.60; maintains FY guidance
--------------------------------------------------------------------------------

- Net sales $6.0B (+2.6% reported, +2.4% organic); MedSurg/Neuro +5.0%, Orthopaedics +0.1%.
- Reported EPS $1.93 (+14.2%); adjusted EPS $2.60 (-8.5%) as adjusted operating margin contracted 180bps to 21.1%.
- Maintains FY2026 guidance: organic sales growth 8.0%-9.5%, adjusted EPS $14.90-$15.10.
- Company highlights recovery from cyber incident and new Ortho Tech organizational structure combining Mako and instruments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076426000025/0000310764-26-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076426000025/syk-20260430.htm
  HTML page:      https://secwatch.observer/filing/0000310764-26-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer